BioNTech's cancer pipeline is bigger than its COVID-era reputation suggests, and the stock still trades below $100.
The U.S. Department of Health and Human Services (HHS) launched a new initiative to accelerate clinical trials on September ...
Clinical trials are a key driver of biotech stocks. Every new therapy must pass through a series of testing, Phase 1, Phase 2 ...
VivoSim is a San Diego biotech company whose goal is to limit the impact of failure in human trials. By using lab-grown human ...
Connecting people with clinical trials is complicated — even if people identify a promising match, there’s a slew of potentially thorny factors, including geographic incompatibility, and financial and ...
The Compliance CRO™, today announced its independent clinical compliance assessment service for biopharmaceutical sponsors, boards, and investors.
Broader community enrollment improves external validity by capturing patients with comorbidities and real-world treatment patterns, while familiarizing clinicians with toxicity management before ...
The U.S. Department of Health and Human Services announced the launching of a new program aimed to remove barriers that slow clinical development and transform how clinical trials are designed and ...
The department announced a broader multi-agency effort to support U.S. clinical trial infrastructure this past summer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results